Back

Community pharmacist intervention to enhance adherence in patients initiating cardiovascular medication: the PHARM-ADHERE randomized controlled trial

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hypertension pharmacotherapy updates Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Adelien Watteyne

Ghent University, Ghent (Belgium)

3 More presentations in this session

Presentation thumbnail
Impact of systolic blood pressure on ischemic and bleeding events and the efficacy and safety of rivaroxaban monotherapy: a post-hoc analysis of the AFIRE trial
Doctor S. Yamanaka (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Genetic inhibition of angiopoietin-like protein 3, 4, and 8 on cardiovascular disease risk
Professor X. Hua (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Efficacy and harms associated with polypills for primary and secondary prevention of cardiovascular disease: a systematic review and meta-analysis.
Professor A. Hernandez (Storrs, US)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study
thumbnail
Congress Session
Late-Breaking Clinical Trials: hypertension
thumbnail
Congress Presentation
OUTREACH - adherence to treatment and blood pressure control

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources